Segmented nucleic acids

The non-nucleotide linker formed through chemical ligation solves the problems of long nucleic acid synthesis and purification, realizes efficient synthesis and the preparation of functional segmented nucleic acids, simplifies the isolation and purification process, and provides effective gene editing and disease treatment. therapeutic agent.

CN118922536APending Publication Date: 2024-11-08钟明宏
7 Cites 0 Cited by

Patent Information

Application Number
CN202280090463.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-14
Filing Date
2022-11-30
Publication Date
2024-11-08

Smart Images

  • Figure CN118922536A_ABST
    Figure CN118922536A_ABST
Patent Text Reader

Abstract

The present invention provides processes and methods for preparing segmented nucleic acids comprising at least two non-nucleotide linkers and conjugates of segmented nucleic acids and RNP complexes thereof with RNA-guided gene editing proteins, including CRISPR Cas proteins and ADAR enzymes. Also disclosed is the use of compositions comprising segmented nucleic acids or conjugates of segmented nucleic acids as medicaments for the treatment of disease.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Chemically ligated RNAs for CRISPR / Cas9-lgRNA complexes as antiviral therapeutic agents

    US10059940B2

  • Crispr oligonucleotides and gene editing

    US20160102322A1

  • Guide RNA with chemical modifications

    US20160289675A1

  • Segmented Nucleic Acids

    US20230167441A1

  • Use of unstructured nucleic acids in assaying nucleic acid molecules

    US7371580B2